266 studies found for:    Lymphoma AND (women OR woman OR female)
Show Display Options
Rank Status Study
21 Active, not recruiting Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
Conditions: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: doxorubicin hydrochloride;   Drug: liposomal vincristine sulfate;   Drug: vinorelbine tartrate;   Drug: cyclophosphamide;   Drug: etoposide phosphate;   Drug: prednisone;   Biological: filgrastim;   Drug: ifosfamide
22 Recruiting A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Condition: Hepatosplenic T-Cell Lymphoma
Intervention: Biological: Collection of samples
23 Active, not recruiting
Has Results
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: Lenalidomide;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Rituximab;   Drug: Etoposide
24 Recruiting Preservation of Ovarian Function After Hematopoietic Cell Transplant
Conditions: Multiple Myeloma;   Non-Hodgkin Lymphoma;   Hodgkin Disease;   Acute Myeloid Leukemia;   Myeloproliferative Disorders
Interventions: Drug: Leuprolide;   Biological: hematopoietic cell transplant;   Biological: reduced intensity allogeneic HCT
25 Recruiting Breast-Sparing Proton Therapy for Hodgkin's Disease
Condition: Hodgkins Disease
Intervention: Radiation: Proton
26 Unknown  Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cladribine;   Drug: temsirolimus;   Genetic: cytogenetic analysis;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry
27 Completed SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Other: biologic sample preservation procedure;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
28 Terminated Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy
Condition: Breast Cancer
Interventions: Procedure: Breast MRI;   Procedure: Mammogram
29 Completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: etoposide;   Drug: melphalan;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation
30 Completed SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Condition: Lymphoma
Intervention: Other: biologic sample preservation procedure
31 Recruiting Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma
Condition: Non-gastric Marginal Zone Lymphoma
Intervention: Radiation: Involved Field Radiotherapy
32 Completed Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: mesna;   Procedure: peripheral blood stem cell transplantation
33 Recruiting Lymphoma Bridge Transplant Study
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Bendamustine;   Drug: Carmustine;   Drug: Etoposide;   Drug: Melphalan;   Drug: Cytarabine;   Drug: Alemtuzumab;   Biological: Autologous Stem Cell Transplantation;   Biological: Allogeneic Stem Cell Transplantation;   Drug: Rituximab
34 Terminated S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: bendamustine hydrochloride;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: vincristine sulfate
35 Completed Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Radiation: yttrium Y 90 ibritumomab tiuxetan
36 Completed Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: epratuzumab;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate
37 Active, not recruiting
Has Results
S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: bortezomib;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate
38 Recruiting Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma
Conditions: Relapsed or Refractory Hodgkin Lymphoma;   Primary Mediastinal Large B-cell Lymphoma
Intervention: Drug: Ruxolitinib
39 Unknown  Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Biological: rituximab
40 Active, not recruiting
Has Results
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Radiation: tositumomab and iodine I 131 tositumomab

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years